James S. Kalus

1.7k total citations
71 papers, 1.3k citations indexed

About

James S. Kalus is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, James S. Kalus has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 10 papers in Internal Medicine. Recurrent topics in James S. Kalus's work include Atrial Fibrillation Management and Outcomes (21 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Cardiac Arrhythmias and Treatments (12 papers). James S. Kalus is often cited by papers focused on Atrial Fibrillation Management and Outcomes (21 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Cardiac Arrhythmias and Treatments (12 papers). James S. Kalus collaborates with scholars based in United States, Türkiye and Germany. James S. Kalus's co-authors include C Michael White, Douglas L. Jennings, Michael F. Caron, Jeffrey Kluger, Craig I Coleman, David E. Lanfear, Helen Berlie, Linda A. Jaber, Jessica Song and Jerry Yee and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

James S. Kalus

68 papers receiving 1.3k citations

Peers

James S. Kalus

CCM

EDM

SURGE

PHEOH

Alessandro Filippi Italy

Ovidio Brignoli Italy

Surakit Nathisuwan Thailand

Jo E. Rodgers United States

James P Sheppard United Kingdom

Pernille Buch Denmark

Mark Munger United States

Barbara S. Wiggins United States

Jeffrey Schein United States

L Vaur France

Alessandro Filippi Italy

James S. Kalus

1.1k ×1.7

CCM

253 ×1.4

EDM

207 ×1.2

SURGE

244 ×1.5

116 ×0.8

PHEOH

Citations per year, relative to James S. Kalus James S. Kalus (= 1×) peers Alessandro Filippi

Countries citing papers authored by James S. Kalus

Since Specialization

Citations

This map shows the geographic impact of James S. Kalus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Kalus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Kalus more than expected).

Fields of papers citing papers by James S. Kalus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Kalus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Kalus. The network helps show where James S. Kalus may publish in the future.

Co-authorship network of co-authors of James S. Kalus

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Kalus. A scholar is included among the top collaborators of James S. Kalus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Kalus. James S. Kalus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Judy W.M., et al.. (2023). Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction. Annals of Pharmacotherapy. 57(11). 1291–1301. 5 indexed citations

Kalus, James S., et al.. (2022). EVALUATION OF GUIDELINE DIRECTED MEDICAL THERAPY IN A PHARMACIST-LED HEART FAILURE CLINIC. Journal of the American College of Cardiology. 79(9). 280–280. 1 indexed citations

Cheng, Judy W.M., et al.. (2020). Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease. Annals of Pharmacotherapy. 55(2). 252–260.

Jennings, Douglas L., et al.. (2014). Epidemiology and Outcomes Associated With Anemia During Long-Term Support With Continuous-Flow Left Ventricular Assist Devices. Journal of Cardiac Failure. 20(6). 387–391. 17 indexed citations

Kalus, James S.. (2013). Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions. SHILAP Revista de lepidopterología. 2013. 1–6. 7 indexed citations

Jennings, Douglas L., et al.. (2010). An Evaluation of the Early Pharmacodynamic Response After Simultaneous Initiation of Warfarin and Amiodarone. The Journal of Clinical Pharmacology. 50(6). 693–698. 14 indexed citations

Krieg, Carsten, et al.. (2009). Receptive music therapy and salivary histamine secretion. Inflammation Research. 59(S2). 217–218. 12 indexed citations

Dowling, Thomas C., John E. Murphy, James S. Kalus, et al.. (2009). Recommended Education for Pharmacists as Competitive Clinical Scientists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(2). 236–244. 26 indexed citations

McBride, Brian F., et al.. (2008). The impact of carvedilol on the defibrillation threshold. Heart & Lung. 37(1). 67–71. 4 indexed citations

10.

Jennings, Douglas L., et al.. (2007). Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysis. Diabetic Medicine. 24(5). 486–493. 97 indexed citations

11.

Fernandez, Rosemarie, Dennis L. Parker, James S. Kalus, Douglas A. Miller, & Scott Compton. (2007). Using a Human Patient Simulation Mannequin to Teach Interdisciplinary Team Skills to Pharmacy Students. American Journal of Pharmaceutical Education. 71(3). 51–51. 87 indexed citations

12.

Kalus, James S., Craig I Coleman, & C Michael White. (2006). The Impact of Suppressing the Renin‐Angiotensin System on Atrial Fibrillation. The Journal of Clinical Pharmacology. 46(1). 21–28. 50 indexed citations

13.

Kalus, James S., et al.. (2006). Practical Application of Nonrandomized Research to Patient Care: A Case Study of Nesiritide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(1). 143–151. 2 indexed citations

14.

Berlie, Helen, James S. Kalus, & Linda A. Jaber. (2006). Thiazolidinediones and the risk of edema: A meta-analysis. Diabetes Research and Clinical Practice. 76(2). 279–289. 82 indexed citations

15.

Jennings, Douglas L., James S. Kalus, & Kate M. O’Dell. (2005). Aldosterone Receptor Antagonism in Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1126–1133. 4 indexed citations

16.

Reddy, Prabashni, James S. Kalus, Michael F. Caron, et al.. (2004). Economic Analysis of Intravenous Plus Oral Amiodarone, Atrial Septal Pacing, and Both Strategies to Prevent Atrial Fibrillation After Open Heart Surgery. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(8). 1013–1019. 6 indexed citations

17.

Kalus, James S., Michael F. Caron, C Michael White, et al.. (2004). Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. The American Journal of Cardiology. 94(11). 1423–1425. 49 indexed citations

18.

Kalus, James S., et al.. (2004). Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. The Annals of Thoracic Surgery. 77(4). 1288–1292. 29 indexed citations

19.

Kalus, James S. & Michael F. Caron. (2004). Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin. Expert Opinion on Investigational Drugs. 13(5). 465–477. 3 indexed citations

20.

Caron, Michael F., et al.. (2003). Effects of Intravenous Magnesium Sulfate on the QT Interval in Patients Receiving Ibutilide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(3). 296–300. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact